AR002949A1 - Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar. - Google Patents

Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar.

Info

Publication number
AR002949A1
AR002949A1 AR10071295A AR10071295A AR002949A1 AR 002949 A1 AR002949 A1 AR 002949A1 AR 10071295 A AR10071295 A AR 10071295A AR 10071295 A AR10071295 A AR 10071295A AR 002949 A1 AR002949 A1 AR 002949A1
Authority
AR
Argentina
Prior art keywords
diagnosing
diabetes
preparations
diagnosis
kit
Prior art date
Application number
AR10071295A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR002949(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of AR002949A1 publication Critical patent/AR002949A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AR10071295A 1994-12-21 1995-12-21 Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar. AR002949A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes

Publications (1)

Publication Number Publication Date
AR002949A1 true AR002949A1 (es) 1998-05-27

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
AR10071295A AR002949A1 (es) 1994-12-21 1995-12-21 Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar.

Country Status (31)

Country Link
EP (1) EP0820303B1 (es)
JP (2) JP3420245B2 (es)
KR (1) KR100400480B1 (es)
CN (1) CN1233417C (es)
AR (1) AR002949A1 (es)
AT (1) ATE242005T1 (es)
AU (1) AU707835B2 (es)
BR (1) BR9510102A (es)
CA (1) CA2208274C (es)
CZ (1) CZ293784B6 (es)
DE (2) DE820303T1 (es)
DK (1) DK0820303T3 (es)
ES (1) ES2201137T3 (es)
FI (1) FI118373B (es)
HR (1) HRP950612B1 (es)
HU (1) HU224160B1 (es)
IL (1) IL116499A0 (es)
IS (1) IS1966B (es)
MX (1) MX9704738A (es)
NO (1) NO317350B1 (es)
NZ (1) NZ301440A (es)
PL (1) PL184145B1 (es)
PT (1) PT820303E (es)
RO (1) RO116777B1 (es)
RS (1) RS49517B (es)
SI (1) SI0820303T1 (es)
TR (1) TR199501630A2 (es)
TW (1) TW496872B (es)
UA (1) UA42040C2 (es)
UY (1) UY24130A1 (es)
WO (1) WO1996019236A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
EP1335741A4 (en) * 2000-08-25 2005-10-26 Yeda Res & Dev METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
CA2595520A1 (en) 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
EP1858545A2 (en) * 2005-03-04 2007-11-28 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
EP2295066B1 (en) 2005-05-25 2016-04-27 CureDM Group Holdings, LLC Peptides, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en) 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
MX337147B (es) 2007-08-30 2016-02-15 Curedm Group Holdings Llc Composiciones y metodos para utilizar peptidos proislet y sus analogos.
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
CN104203263A (zh) 2012-03-01 2014-12-10 耶达研究与发展有限公司 利用HSP60衍生肽再生胰岛β细胞
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
KR100400480B1 (ko) 2003-12-31
RS49517B (sr) 2006-10-27
UY24130A1 (es) 1996-06-11
NO972849D0 (no) 1997-06-19
WO1996019236A1 (en) 1996-06-27
JPH10511649A (ja) 1998-11-10
FI972669A (fi) 1997-08-15
MX9704738A (es) 1997-10-31
CA2208274C (en) 2005-12-06
HU224160B1 (hu) 2005-06-28
ES2201137T3 (es) 2004-03-16
TW496872B (en) 2002-08-01
FI972669A0 (fi) 1997-06-19
NO317350B1 (no) 2004-10-18
IS1966B (is) 2004-12-15
PL321091A1 (en) 1997-11-24
EP0820303A1 (en) 1998-01-28
PL184145B1 (pl) 2002-09-30
IS4510A (is) 1997-06-19
JP3420245B2 (ja) 2003-06-23
HRP950612B1 (en) 2003-12-31
SI0820303T1 (en) 2003-10-31
DE69531004D1 (de) 2003-07-10
JP3554319B2 (ja) 2004-08-18
AU707835B2 (en) 1999-07-22
CA2208274A1 (en) 1996-06-27
AU4686696A (en) 1996-07-10
NZ301440A (en) 2000-01-28
EP0820303B1 (en) 2003-06-04
HUT78092A (hu) 1999-09-28
HRP950612A2 (en) 1997-10-31
RO116777B1 (ro) 2001-06-29
PT820303E (pt) 2003-10-31
IL116499A0 (en) 1996-03-31
TR199501630A2 (tr) 1996-07-21
ATE242005T1 (de) 2003-06-15
DK0820303T3 (da) 2003-10-06
DE69531004T2 (de) 2004-02-05
JP2004026797A (ja) 2004-01-29
DE820303T1 (de) 1999-05-20
UA42040C2 (uk) 2001-10-15
CZ190897A3 (en) 1997-11-12
YU78795A (sh) 1998-05-15
BR9510102A (pt) 1997-11-25
NO972849L (no) 1997-08-13
FI118373B (fi) 2007-10-31
CN1175214A (zh) 1998-03-04
CN1233417C (zh) 2005-12-28
EP0820303A4 (es) 1998-03-11
CZ293784B6 (cs) 2004-07-14

Similar Documents

Publication Publication Date Title
AR002949A1 (es) Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar.
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
DE69000641D1 (de) Imipramin enthaltende arzneizubereitungen.
MX9207222A (es) Procedimiento para la preparacion de compuestos farmaceuticos que reducen selectivamente el nivel de lipidos de la sangre.
HUP0000432A2 (hu) Inzulin C-peptidek
DE3170587D1 (en) The use of peptides as medicaments and certain novel peptides
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto
NO893288D0 (no) Fremgangsmaate for fremstilling av et nytt antibiotikum, mersacidin, og anvendelse derav som legemiddel.
DK88087D0 (da) Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem
DE69417340D1 (de) Spritze für medizinische zwecke
PT946567E (pt) Novos analogos da camptotecina, sua utilizacao como madicamentos e composicoes farmaceuticas que os contem
FI971427A (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
RU94002476A (ru) Лекарственное средство
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
BR9505295A (pt) Benzoilguanidina processo para a sua preparação uso da mesma processo para o tratamento de arritmias e drogas
MX9202987A (es) Analogos de insulina, formulacion farmaceutica que los contiene y procedimiento para obtener dichos analogos.
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
ITRM910216A0 (it) Procedimento per la preparazione di composti amminici aromatici e relativo agente riducente. (caso 156-7123)
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
MX9102627A (es) Composicion farmaceutica de dobutamina para administracion transdermica.
MX9200862A (es) Analogos de peptidos y procedimiento para su preparacion.
MX17601A (es) Composicion para el tratamiento de leishmaniasis yprocedimiento para su preparacion .
ES1018866Y (es) Detector individual para el diagnostico previo de la celulitis.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.